Find the latest pharmaceutical market place for formulations enquiry about Dasatinib on PharmaCompass.com.

Various Finished Formulation needed in China [ENA19990]

A CDMO that focuses on the development of various finished formulations, including creams, emulsions, liquids, solutions, films, and OSDs is looking for various finished formulations for commercial purposes. The required quantity is 20,000 boxes - 30,000 boxes.
1. Capecitabine (500 mg) Tablets or Capsules
2. Dasatinib (50 mg) Tablets or Capsules
3. Enzalutamide (160 mg) Tablets or Capsules
4. Nilotinib (200 mg) Tablets or Capsules
5. Imatinib Mesylate (400 mg) Tablets or Capsules
6. Midostaurin (25 mg) Tablets or Capsules
7. Sunitinib Malate (50 mg) Tablets or Capsules
8. Tofacitinib XR (11 mg) Tablets or Capsules
9. Pazopanib (400 mg) Tablets or Capsules
10. Adagrasib (200 mg) Tablets or Capsules
11. Apalutamide (60 mg) Tablets or Capsules
12. Fingolimod (0.5 mg) Tablets or Capsules
13. Nintedanib (150 mg) Tablets or Capsules
14. Valganciclovir (450 mg) Tablets or Capsules

Reply

16 Jul 2024

india-flag Flag

Various RLDs needed in India [ENA19217]

A CDMO that focuses on the development, manufacturing & marketing of niche finished formulations is looking for suppliers of Various RLDs for commercial purposes.
1. Paclitaxel (100 mg/ ml) Injection - Acopacli Na 100 mg. The required quantity is 1 Unit.
2. Dasatinib (100 mg) Tablet - Asatinib 100 Mg. The required quantity is 30 Units.
3. Dasatinib (50 mg) Tablet - Asatinib 50 Mg. The required quantity is 60 Units.
4. Lenvatinib (4 mg) Capsules - Lentinib 4 mg. The required quantity is 30 Units.
5. Lenvatinib (10 mg) Capsules - Lentinib 10 mg. The required quantity is 30 Units.
6. Abiraterone Acetate (250 mg) Tablet - Acobirate 250mg. The required quantity is 120 Units.

Reply

19 Mar 2024

CzechRepublic Flag

Tender// Dasatinib (20 mg) Tablets needed in Czech Republic [ENA16588]

Olomouc University Hospital is looking for supplies of Dasatinib (20 mg) Tablets for commercial purposes. The required quantity is 1,341 units. The deadline is 11-Apr-2023.

Reply

13 Mar 2023

Dasatinib (20 mg, 50 mg, 70 mg, 80 mg, 100 mg & 140 mg) Tablets needed in Romania [ENA12297]

A large pharmaceutical company that devotes itself to R&D, production and marketing & sales of active pharmaceutical ingredients and pharmaceutical intermediates is looking for suppliers of Dasatinib (20 mg, 50 mg, 70 mg, 80 mg, 100 mg & 140 mg) Tablets for commercial purposes. The suppliers must support this enquiry this EU-GMP & EUCTD Dossier. The final market is Romania & Russia.

Reply

04 Jan 2022

Various Finished Dosage Formulations needed in Thailand [ENA09995]

A company that aims to conduct a bioequivalence study of their generic drugs at utmost quality standards is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The suppliers must support this enquiry with PIC/S Dossier and BE study.
1. Capecitabine (500 mg) Tablets
2. Enoxaparin (60 mg/ 0.6 ml & 40 mg/ 0.4 ml) Injections
3. Sorafenib (200 mg) Tablets
4. Dasatinib (50 mg) Tablets
5. Sunitinib (12.5 mg) Capsules
6. Enzalutamide (40 mg) Tablets

Reply

19 Mar 2021

india-flag Flag

Looking for anticancer formulations in India [ENA02276]

Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to over 70 markets around the world is looking for suppliers of the following anticancer formulations:
1) Capecitabine Tablets
2) Dasatinib Tablets
3) Everolimus
4) Sorafenib
5) Lenalidomide
Interested suppliers must contact Kumar. P via E-mail: rajkumar.pachimatla@gmail.com or Tel: 8248256894.

Reply

12 Oct 2018

Enquiry// Imatinib, Dasatinib and various other FDFs required in Colombia [ENA00163]

A leading supplier of raw materials, active ingredients, excipients and packaging material for the pharmaceutical, veterinary and agrochemical industries is searching for suppliers of Adalimumab 40 mg/0.8 ml - 50 mg/ml Inj. solution 6000 vials, Infliximab 100 mg 4000 vials, Abatacept 125 mg/ml (4 vials/box) 4000 Boxes, Abatacept 250 mg/ml (4 vials/box), Tocilizumab 200 mg/10 ml 4000 vials, Tocilizumab 80 mg/4 ml 4000 vials, Certolizumab 200 mg/ml 3000 vials, Dasatinib 70 MG (7 tabs/box) 4000 boxes, Imatinib 100 mg (7 tabs/box) 4000 boxes and Imatinib 400 mg (7 tabs/box) 4000 boxes with GMP and dossier support from regulated markets for commercialization in Colombia.

Reply

20 Jan 2017